What is the evidence base to guide surgical treatment of infected hip prostheses? systematic review of longitudinal studies in unselected patients

BMC Medicine

Ashley W Blom²  Andrew Lovering¹  Rachael Gooberman-Hill²  Alison J Smith²  Karen T Elvers²  Andrew D Beswick² 

[1] Department of Microbiology, North Bristol NHS Trust, Bristol Centre for Antimicrobial Research and Enterprise, Southmead Hospital, Southmead Road, Bristol, BS9 3HU, UK;School of Clinical Sciences, University of Bristol, Musculoskeletal Research Unit, Southmead Hospital, Southmead Road, Bristol, BS10 5NB, UK

关键词: systematic review;    revision;    infection;    hip arthroplasty;    hip replacement;   

Others  :  1126405
DOI  :  10.1186/1741-7015-10-18

 received in 2012-01-03, accepted in 2012-02-16,  发布年份 2012

【 摘 要 】

Background

Prosthetic joint infection is an uncommon but serious complication of hip replacement. There are two main surgical treatment options, with the choice largely based on the preference of the surgeon. Evidence is required regarding the comparative effectiveness of one-stage and two-stage revision to prevent reinfection after prosthetic joint infection.

Methods

We conducted a systematic review to identify randomised controlled trials, systematic reviews and longitudinal studies in unselected patients with infection treated exclusively by one- or two-stage methods or by any method. The Embase, MEDLINE and Cochrane databases were searched up to March 2011. Reference lists were checked, and citations of key articles were identified by using the ISI Web of Science portal. Classification of studies and data extraction were performed independently by two reviewers. The outcome measure studied was reinfection within 2 years. Data were combined to produce pooled random-effects estimates using the Freeman-Tukey arc-sine transformation.

Results

We identified 62 relevant studies comprising 4,197 patients. Regardless of treatment, the overall rate of reinfection after any treatment was 10.1% (95% CI = 8.2 to 12.0). In 11 studies comprising 1,225 patients with infected hip prostheses who underwent exclusively one-stage revision, the rate of reinfection was 8.6% (95% CI = 4.5 to 13.9). After two-stage revision exclusively in 28 studies comprising 1,188 patients, the rate of reinfection was 10.2% (95% CI = 7.7 to 12.9).

Conclusion

Evidence of the relative effectiveness of one- and two-stage revision in preventing reinfection of hip prostheses is largely based on interpretation of longitudinal studies. There is no suggestion in the published studies that one- or two stage methods have different reinfection outcomes. Randomised trials are needed to establish optimum management strategies.

【 授权许可】

   
2012 Beswick et al; licensee BioMed Central Ltd.

【 参考文献 】

• [1]National Joint Registry for England and Wales (NJR): [http:/ / www.njrcentre.org.uk/ NjrCentre/ Portals/ 0/ NJR%207th%20Annual%20Report%202010. pdf] webcite7th Annual Report 2010. Hemel Hempstead: NJR Centre; 2010.
• [2]DeFrances CJ, Lucas CA, Buie VC, Golosinskiy A: 2006 National Hospital Discharge Survey. Natl Health Stat Report 2008, 5:1-20.
• [3]Kurtz S, Ong K, Lau E, Mowat F, Halpern M: Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am 2007, 89:780-785.
• [4]Matthews PC, Berendt AR, McNally MA, Byren I: Diagnosis and management of prosthetic joint infection. BMJ 2009, 338:b1773.
• [5]Blom AW, Taylor AH, Pattison G, Whitehouse S, Bannister GC: Infection after total hip arthroplasty: the Avon experience. J Bone Joint Surg Br 2003, 85:956-959.
• [6]Phillips JE, Crane TP, Noy M, Elliott TSJ, Grimer RJ: The incidence of deep prosthetic infections in a specialist orthopaedic hospital: a 15-year prospective survey. J Bone Joint Surg Br 2006, 88:943-948.
• [7]Kurtz SM, Lau E, Schmier J, Ong KL, Zhao K, Parvizi J: Infection burden for hip and knee arthroplasty in the United States. J Arthroplasty 2008, 23:984-991.
• [8]Zimmerli W, Trampuz A, Ochsner PE: Prosthetic-joint infections. N Engl J Med 2004, 351:1645-1654.
• [9]Andersson AE, Bergh I, Karlsson J, Nilsson K: Patients' experiences of acquiring a deep surgical site infection: an interview study. Am J Infect Control 2010, 38:711-717.
• [10]Hunter G, Dandy D: The natural history of the patient with an infected total hip replacement. J Bone Joint Surg Br 1977, 59:293-297.
• [11]Vilchez F, Martínez-Pastor JC, García-Ramiro S, Bori G, Maculé F, Sierra J, Font L, Mensa J, Soriano A: Outcome and predictors of treatment failure in early post-surgical prosthetic joint infections due to Staphylococcus aureus treated with debridement. Clin Microbiol Infect 2011, 17:439-444.
• [12]Byren I, Bejon P, Atkins BL, Angus B, Masters S, McLardy-Smith P, Gundle R, Berendt A: One hundred and twelve infected arthroplasties treated with 'DAIR' (debridement, antibiotics and implant retention): antibiotic duration and outcome. J Antimicrob Chemother 2009, 63:1264-1271.
• [13]Maurer TB, Zimmerli W, Ochsner PE: The role of a treatment algorithm to guide one- or two-stage exchange in periprosthetic hip joint infection [abstract S09.6]. J Bone Joint Surg Br 2011, 93(Suppl III):331-332.
• [14]Klouche S, Sariali E, Mamoudy P: Total hip arthroplasty revision due to infection: a cost analysis approach. Orthop Traumatol Surg Res 2010, 96:124-132.
• [15]Higgins JPT, Green S (Eds): [http://www.cochrane-handbook.org/] webciteIn Cochrane Handbook for Systematic Reviews of Interventions version 5.1.0. (updated March 2011). The Cochrane Collaboration; 2011.
• [16]Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB, the Meta-analysis of Observational Studies in Epidemiology (MOOSE) Group: Meta-analysis of observational studies in epidemiology: a proposal for reporting. JAMA 2000, 283:2008-2012.
• [17]Gallo J, Smizanský M, Radová L, Potomková J: [Comparison of therapeutic strategies for hip and knee prosthetic joint infection] [in Czech]. Acta Chir Orthop Traumatol Cech 2009, 76:302-309.
• [18]Wolf CF, Gu NY, Doctor JN, Manner PA, Leopold SS: Comparison of one and two-stage revision of total hip arthroplasty complicated by infection: a Markov expected-utility decision analysis. J Bone Joint Surg Am 2011, 93:631-639.
• [19]Buchholz H, Elson R, Engelbrecht E, Lodenkämper H, Röttger J, Siegel A: Management of deep infection of total hip replacement. J Bone Joint Surg Br 1981, 63:342-353.
• [20]Loty B, Postel M, Evrard J, Matron P, Courpied JP, Kerboull M, Tomeno B: [One stage revision of infected total hip replacements with replacement of bone loss by allografts: study of 90 cases of which 46 used bone allografts] [in French]. Int Orthop 1992, 16:330-338.
• [21]Miley GB, Scheller AD, Turner RH: Medical and surgical treatment of the septic hip with one-stage revision arthroplasty. Clin Orthop Relat Res 1982, 170:76-82.
• [22]Raut VV, Siney PD, Wroblewski BM: One-stage revision of total hip arthroplasty for deep infection: long-term followup. Clin Orthop Relat Res 1995, 321:202-207.
• [23]Schneider R: [The infected total prosthesis] [in German]. Orthopade 1989, 18:527-532.
• [24]Wroblewski BM: One-stage revision of infected cemented total hip arthroplasty. Clin Orthop Relat Res 1986, 211:103-107.
• [25]Chen WS, Fu TH, Wang JW: Two-stage reimplantation of infected hip arthroplasties. Chang Gung Med J 2009, 32:188-197.
• [26]Fitzgerald RH, Jones DR: Hip implant infection: treatment with resection arthroplasty and late total hip arthroplasty. Am J Med 1985, 78:225-228.
• [27]Haddad FS, Muirhead-Allwood SK, Manktelow AR, Bacarese-Hamilton I: Two-stage uncemented revision hip arthroplasty for infection. J Bone Joint Surg Br 2000, 82:689-694.
• [28]Hsieh PH, Huang KC, Lee PC, Lee MS: Two-stage revision of infected hip arthroplasty using an antibiotic-loaded spacer: retrospective comparison between short-term and prolonged antibiotic therapy. J Antimicrob Chemother 2009, 64:392-397.
• [29]Romanò CL, Romanò D, Logoluso N, Meani E: Long-stem versus short-stem preformed antibiotic-loaded cement spacers for two-stage revision of infected total hip arthroplasty. Hip Int 2010, 20:26-33.
• [30]Stockley I, Mockford BJ, Hoad-Reddick A, Norman P: The use of two-stage exchange arthroplasty with depot antibiotics in the absence of long-term antibiotic therapy in infected total hip replacement. J Bone Joint Surg Br 2008, 90:145-148.
• [31]Toulson C, Walcott-Sapp S, Hur J, Salvati E, Bostrom M, Brause B, Westrich GH: Treatment of infected total hip arthroplasty with a 2-stage reimplantation protocol: update on "our institution's" experience from 1989 to 2003. J Arthroplasty 2009, 24:1051-1060.
• [32]McDonald DJ, Fitzgerald RH Jr, Ilstrup DM: Two-stage reconstruction of a total hip arthroplasty because of infection. J Bone Joint Surg Am 1989, 71:828-834.
• [33]De Man FH, Sendi P, Zimmerli W, Maurer TB, Ochsner PE, Ilchmann T: Infectiological, functional, and radiographic outcome after revision for prosthetic hip infection according to a strict algorithm. Acta Orthop 2011, 82:27-34.
• [34]Elson RA: One-stage exchange in the treatment of the infected total hip arthroplasty. Semin Arthroplasty 1994, 5:137-141.
• [35]Ketterl R, Henly MB, Stübinger B, Beckurts T, Claudi B: Analysis of three operative techniques for infected total hip replacements. Orthop Trans 1988, 12:715.
• [36]Ladero Morales F, Fernandez Gonzalez J, Blanco Ortiz F, Martinez Martin J, Garcia Araujo C: [Treatment of infected hip arthroplasty: retrospective study] [in Spanish]. Rev Ortop Traumatol 1999, 43:84-92.
• [37]Lecuire F, Collodel M, Basso M, Rubini J, Gontier D, Carrère J: [Revision of infected total hip prostheses by ablation reimplantation of an uncemented prosthesis: 57 case reports] [in French]. Rev Chir Orthop Reparatrice Appar Mot 1999, 85:337-348.
• [38]Oussedik SI, Dodd MB, Haddad FS: Outcomes of revision total hip replacement for infection after grading according to a standard protocol. J Bone Joint Surg Br 2010, 92:1222-1226.
• [39]Sanzén L, Carlsson A, Josefsson G, Lindberg LT: Revision operations on infected total hip arthroplasties: two- to nine-year follow-up study. Clin Orthop Relat Res 1988, 229:165-172.
• [40]Vielpeau C, Lortat-Jacob A: [Management of the infected hip prostheses] [in French]. Rev Chir Orthop Reparatrice Appar Mot 2002, 88(Suppl 1):159-216.
• [41]Elson RA: Exchange arthroplasty for infection: perspectives from the United Kingdom. Orthop Clin North Am 1993, 24:761-767.
• [42]Carlsson A, Josefsson G, Lindberg L: Revision with gentamicin-impregnated cement for deep infections in total hip arthroplasties. J Bone Joint Surg Am 1978, 60:1059-1064.
• [43]Jämsen E, Stogiannidis I, Malmivaara A, Pajamäki J, Puolakka T, Konttinen YT: Outcome of prosthesis exchange for infected knee arthroplasty: the effect of treatment approach. Acta Orthop 2009, 80:67-77.
• [44]Wilson PD, Aglietti P, Salvati EA: Subacute sepsis of the hip treated by antibiotics and cemented prosthesis. J Bone Joint Surg Am 1974, 56:879-898.
• [45]Wylde V, Blom AW: The failure of survivorship. J Bone Joint Surg Br 2011, 93:569-570.
• [46]Leung F, Richards CJ, Garbuz DS, Masri BA, Duncan CP: Two-stage total hip arthroplasty: how often does it control methicillin-resistant infection? Clin Orthop Relat Res 2011, 469:1009-1015.
• [47]Jung J, Schmid NV, Kelm J, Schmitt E, Anagnostakos K: Complications after spacer implantation in the treatment of hip joint infections. Int J Med Sci 2009, 6:265-273.
• [48]Department of Health, National Health Service (NHS) Trust: Confirmation of Payment by Results (PbR) Arrangements for 2010-11. [http:/ / www.dh.gov.uk/ prod_consum_dh/ groups/ dh_digitalassets/ @dh/ @en/ @ps/ documents/ digitalasset/ dh_112970.pdf] webcite
• [49]Riley RD, Lambert PC, Abo-Zaid G: Meta-analysis of individual participant data: rationale, conduct, and reporting. BMJ 2010, 340:521-525.
• [50]Shrier I, Platt RW, Steele RJ: Mega-trials vs. meta-analysis: precision vs. heterogeneity? Contemp Clin Trials 2007, 28:324-328.